GlassScriptPhysician profile
Emily Chau
NPI 1629598461
$11,832.11
in general payments reported to CMS, 2019-2025
27 companies · $177 in 2025
The $177 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,235 · 2020: $1,603 · 2021: $313 · 2022: $245 · 2023: $573 · 2024: $1,688 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,435 · Food and Beverage: $1,002.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,435.10 |
| Food and Beverage | $1,002.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supreme Orthopedic Systems, LLC | $6,575.06 | 2019-2020 | |
| Saxum Surgical, INC. | $1,217.67 | 2023-2024 | |
| Arthrex, INC. | $896.65 | 2019-2024 | |
| Stryker Corporation | $896.15 | 2019-2024 | Dart-Fire, Actishield |
| Orthofix Medical, INC. | $626.23 | 2019 | |
| Nevro Corp. | $436.59 | 2022-2024 | Senza |
| Smith+Nephew, INC. | $191.20 | 2020-2025 | Grafix Pl, Grafix |
| Bioventus LLC | $143.21 | 2022-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Horizon Therapeutics Plc | $107.66 | 2021-2023 | Krystexxa |
| Abbvie INC. | $94.79 | 2021-2022 | |
| Solventum Corporation | $82.59 | 2024-2025 | 3m Cavilon, Activ.A.C., 3m Coban |
| Depuy Synthes Sales INC. | $73.35 | 2022-2024 | |
| Organogenesis INC. | $66.28 | 2021-2023 | Puraply |
| Kci USA, INC. | $63.53 | 2021-2023 | Activ.A.C., V.A.C. Dermatac |
| Paratek Pharmaceuticals, INC. | $61.75 | 2020-2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $45.80 | 2023-2024 | Eterna, Proclaim |
| Integra Lifesciences Corporation | $40.52 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Biotissue Holdings INC. | $39.42 | 2024 | |
| Melinta Therapeutics, LLC | $31.74 | 2021 | |
| Amgen INC. | $30.86 | 2024 | Krystexxa |
| Ibsa Pharma INC. | $19.89 | 2023 | Tirosint, Licart |
| Fusion Orthopedics USA, LLC | $19.85 | 2024 | |
| Hartmann USA, INC. | $19.13 | 2022 | |
| Zimmer Biomet Holdings, INC. | $14.77 | 2021 | |
| Tactile Systems Technology INC | $14.49 | 2021 | |
| Convatec INC. | $12.59 | 2020 | |
| Paragon 28, INC. | $10.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Chau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.